Hotstocked Newsletters

Paying Parties

PAYING PARTY DETAILS

Edge Media LLC campaign for ATNM

Emails Sent: 6
Estimated volume generated: $1,667,116
Total Paid: $60,000

E-MAILS SENT FOR THIS CAMPAIGN:

SORT:
  View this email in your browser Good morning members, We saw a halt this afternoon in trading of Actinium's securities which sent it on a roller coaster ride awaiting a substantial announcement by the company. A lot of you are wondering why the stock went up after an offering was announced at a 15% discount to the market. Let me explain…  The key here ...read more
Promoter: Otcbb Journal
Stocks covered: Compensation: Avg $ Volume for Period:
ATNM $60,000 UNKNOWN
Max Profit: 6.25 % Gain at close: -5.94 %
    View this email in your browser Good morning members, We saw a halt this afternoon in trading of Actinium's securities which sent it on a roller coaster ride awaiting a substantial announcement by the company. A lot of you are wondering why the stock went up after an offering was announced at a 15% discount to the market. Let me explain…  ...read more
Promoter: Stocks Impossible
Stocks covered: Compensation: Avg $ Volume for Period:
ATNM $60,000 UNKNOWN
Max Profit: 6.25 % Gain at close: -5.94 %
  View this email in your browser Good morning everyone, Our own Small-Cap oracle has identified this potentially undervalued biotech play. Actinium Pharmaceuticals Inc. (NYSE-MKT: ATNM) “There are three targeted therapies for attacking cancerous cells in the human body: alpha-emitters, beta-emitters, and toxins. The company competes with one other ...read more
Promoter: First Penny Picks
Stocks covered: Compensation: Avg $ Volume for Period:
ATNM $60,000 1,667,116
Max Profit: 6.25 % Gain at close: -5.94 %
  View this email in your browser Good morning everyone, Our own Small-Cap oracle has identified this potentially undervalued biotech play. Actinium Pharmaceuticals Inc. (NYSE-MKT: ATNM) “There are three targeted therapies for attacking cancerous cells in the human body: alpha-emitters, beta-emitters, and toxins. The company competes with one other ...read more
Promoter: Stocks Impossible
Stocks covered: Compensation: Avg $ Volume for Period:
ATNM $60,000 1,667,116
Max Profit: 6.25 % Gain at close: -5.94 %
  View this email in your browser Good morning everyone, Our own Small-Cap oracle has identified this potentially undervalued biotech play. Actinium Pharmaceuticals Inc. (NYSE-MKT: ATNM) “There are three targeted therapies for attacking cancerous cells in the human body: alpha-emitters, beta-emitters, and toxins. The company competes with one other ...read more
Promoter: Otcbb Journal
Stocks covered: Compensation: Avg $ Volume for Period:
ATNM $60,000 1,667,116
Max Profit: 6.25 % Gain at close: -5.94 %
  View this email in your browser Good morning everyone, Our own Small-Cap oracle has identified this potentially undervalued biotech play. Actinium Pharmaceuticals Inc. (NYSE-MKT: ATNM) “There are three targeted therapies for attacking cancerous cells in the human body: alpha-emitters, beta-emitters, and toxins. The company competes with one other ...read more
Promoter: Street Picks
Stocks covered: Compensation: Avg $ Volume for Period:
ATNM $60,000 1,667,116
Max Profit: 6.25 % Gain at close: -5.94 %